dromlakhani Add eflornithine topical cream during photoepilation for faster response
STEP 1 — Gather Information
Collect menstrual history, Ferriman–Gallwey score, assessment of patient-important hirsutism despite cosmetic measures, hair and skin type (Fitzpatrick), current photoepilation protocol, contraception status if antiandrogens may be considered later, and baseline hair count or photographic record. Document baseline and eligibility.
STEP 2 — Rule In / Rule Out
Does the patient desire a more rapid response to photoepilation? If yes, proceed to Step 3; if no, continue photoepilation alone and reassess at routine interval.
STEP 3 — Classify or Stratify
Confirm presence of pigmented terminal hair (brown/black) suitable for photoepilation; if hair is white or blonde, recommend electrolysis instead.
STEP 4 — Decide
Prescribe eflornithine 13.9% cream twice daily to affected facial areas, continue photoepilation per manufacturer settings, and schedule follow‑up at 6–8 weeks to evaluate accelerated hair‑growth reduction.
Clinical Guardrails / Mimics / Pitfalls
Do not use in pregnancy or lactation; monitor for local irritation, pruritus, or hyperpigmentation; avoid in patients with known hypersensitivity to eflornithine. Ensure proper skin cooling with long‑wavelength lasers in darker skin to mitigate paradoxical hypertrichosis risk. Remember that eflornithine effect is reversible after discontinuation and does not confer permanent hair removal.
Concrete Clinical Example
A 30‑year‑old woman with PCOS (Ferriman–Gallwey 15) began alexandrite laser for facial hirsutism; after 4 sessions she noted minimal change and requested faster results. Eflornithine cream 13.9% BID was added. At 8 weeks, photographic assessment showed 55% reduction in hair count versus the expected 35% with laser alone.
Source: Evaluation and Treatment of Hirsutism in Premenopausal Women, Endocrine Society Clinical Practice Guideline, 2018, doi:10.1210/jc.2018-00241